Pediatric Neurology Briefs (Apr 2016)

Clinical and Molecular Characterization of ALG1-CDG

  • Radhika Dhamija,
  • Chelsea Chambers

DOI
https://doi.org/10.15844/pedneurbriefs-30-2-5
Journal volume & issue
Vol. 30, no. 2

Abstract

Read online

Investigators from the Human Genetics Program, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, California and a large study group utilized a combination of exome sequencing, targeted gene panels, and Sanger sequencing to identify thirty-one pathogenic variants in thirty-nine affected individuals with ALG1-CDG from 32 families.

Keywords